Diazinon


Curated chemical-phenotype interactions from CTD
GO IDGO nameInteraction typeReference
GO:0000723 Telomere maintenance Affects phenotype PMID:25018261
GO:0000737 Dna catabolic process, endonucleolytic Increases phenotype PMID:34830855
GO:0001808 Negative regulation of type iv hypersensitivity Increases phenotype PMID:36114367
GO:0002921 Negative regulation of humoral immune response Increases phenotype PMID:36114367
GO:0003016 Respiratory system process Decreases phenotype PMID:31981688
GO:0004104 Cholinesterase activity Affects phenotype PMID:30359674
GO:0004602 Glutathione peroxidase activity Decreases phenotype PMID:35403302
GO:0006117 Acetaldehyde metabolic process Affects phenotype PMID:34830855
GO:0006855 Xenobiotic transmembrane transport Decreases phenotype PMID:31251962
GO:0006909 Phagocytosis Decreases phenotype PMID:28119078
GO:0006915 Apoptotic process Increases phenotype PMID:27920530
GO:0006954 Inflammatory response Increases phenotype PMID:30359674; PMID:30359674; PMID:35403302; PMID:35403302
GO:0006974 Cellular response to dna damage stimulus Increases phenotype PMID:26198647
GO:0007613 Memory Decreases phenotype PMID:31704166
GO:0008283 Cell population proliferation Affects phenotype PMID:19589100; PMID:34830855
GO:0008285 Negative regulation of cell population proliferation Increases phenotype PMID:35934178
GO:0008292 Acetylcholine biosynthetic process Decreases phenotype PMID:31251962
GO:0009103 Lipopolysaccharide biosynthetic process Increases phenotype PMID:28369659
GO:0009410 Response to xenobiotic stimulus Affects phenotype PMID:31251962
GO:0016042 Lipid catabolic process Increases phenotype PMID:29383019; PMID:30359674; PMID:30359674
GO:0018158 Protein oxidation Increases phenotype PMID:29383019; PMID:30359674; PMID:30359674
GO:0019627 Urea metabolic process Affects phenotype PMID:32911022
GO:0019637 Organophosphate metabolic process Affects phenotype PMID:38734222
GO:0030263 Apoptotic chromosome condensation Affects phenotype PMID:31981688
GO:0031175 Neuron projection development Decreases phenotype PMID:24561003
GO:0031987 Locomotion involved in locomotory behavior Increases phenotype PMID:31704166; PMID:35452779
GO:0034440 Lipid oxidation Increases phenotype PMID:24392635; PMID:24392635; PMID:27353299; PMID:27353299
GO:0035640 Exploration behavior Decreases phenotype PMID:31704166
GO:0036343 Psychomotor behavior Decreases phenotype PMID:26297601
GO:0040015 Negative regulation of multicellular organism growth Increases phenotype PMID:28369659
GO:0042311 Vasodilation Increases phenotype PMID:24392635
GO:0042593 Glucose homeostasis Affects phenotype PMID:35403302
GO:0043065 Positive regulation of apoptotic process Increases phenotype PMID:27353299
GO:0043256 Laminin complex Decreases phenotype PMID:32911022
GO:0045687 Positive regulation of glial cell differentiation Decreases phenotype PMID:27816694
GO:0045907 Positive regulation of vasoconstriction Increases phenotype PMID:24392635
GO:0045919 Positive regulation of cytolysis Increases phenotype PMID:35934178
GO:0045930 Negative regulation of mitotic cell cycle Increases phenotype PMID:26198647
GO:0046541 Saliva secretion Increases phenotype PMID:31981688
GO:0046683 Response to organophosphorus Affects phenotype PMID:31981688
GO:0050765 Negative regulation of phagocytosis Increases phenotype PMID:36114367
GO:0050890 Cognition Decreases phenotype PMID:31704166
GO:0051092 Positive regulation of nf-kappab transcription factor activity Increases phenotype PMID:30978295
GO:0051881 Regulation of mitochondrial membrane potential Affects phenotype PMID:27920530
GO:0055078 Sodium ion homeostasis Affects phenotype PMID:32911022
GO:0070265 Necrotic cell death Increases phenotype PMID:30359674
GO:0070509 Calcium ion import Decreases phenotype PMID:36347328
GO:0070994 Detection of oxidative stress Increases phenotype PMID:35403302
GO:0090398 Cellular senescence Increases phenotype PMID:34830855
GO:0140042 Lipid droplet formation Increases phenotype PMID:33872936
GO:1902512 Positive regulation of apoptotic dna fragmentation Increases phenotype PMID:35934178
GO:1903409 Reactive oxygen species biosynthetic process Increases phenotype PMID:26198647; PMID:28119078; PMID:30359674
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.